Rubella virus surface glycoproteins (E1 and E2) (RUBV E1/E2)

Rubella virus surface glycoproteins, E1 and E2, are the primary structural components of the viral envelope and serve as the main targets for the host immune response (UniProt P03310). E1 is the major immunodominant protein responsible for membrane fusion and receptor binding, while E2 acts as a chaperone for E1 transport and may also play a role in attachment (PubMed: 16439535). These proteins are critical for the virus's ability to infect host cells and cause Rubella, a contagious viral infection that can lead to severe birth defects known as Congenital Rubella Syndrome (CRS) if contracted during pregnancy (CDC, 2020). Therapeutic strategies primarily focus on prevention through live-attenuated vaccines, such as the RA 27/3 strain, which elicit long-lasting neutralizing antibodies against these glycoproteins (StatPearls, 2023). Understanding the structure and function of E1 and E2 is essential for monitoring vaccine efficacy and developing potential antiviral or passive immunization therapies (PubMed: 24501060).

Other names

Rubella virus envelope proteinsE1 glycoproteinE2 glycoproteinRubella virus spike proteinsRubella virus virion

Induction of neutralizing antibodies that block viral attachment and membrane fusion mediated by E1 and E2 glycoproteins.